Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Novel Multiplex Diagnostic Assays for Diagnosis of Porcine Respiratory Disease Complex


Technology Benefits

FMIA has several advantages over traditional ELISA test format, including improved sensitivity and the ability to multiplex (i.e., detects multiple pathogens in a single test sample simultaneously). Development of rapid, multiplex, cost effective diagnostic tests will be important in population-based epidemiological studies, which provide important data on the early identification of susceptible groups in the population and evaluation of vaccination and herd management strategies. In addition, oral fluid sampling has marked advantages over serum sampling, including lower labor and materials costs,noninvasive collection and lower biosecurity risks because samples can be collected by site personnel. This is more important in the PRDC surveillance program at a population level, which represents a significant breakthrough in our effort to control PRDC, because it will be a major improvement in our ability to cheaply, efficiently track infections in both populations and individual (crated) animals.


Detailed Technology Description

In aid of PRDC prevention and control, SDSU developed rapid, multiplex, cost effective diagnostic assays using oral fluid and serum samples. SDSU developed fluorescent immunomicrosphere assay (FMIA) for PRRSV antigen and antibody detection. SDSU further adapted and optimize PRRSV FMIA test for multiplex detection of SIV, PCV2 and other swine pathogens simultaneously.


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View